Thursday, April 10, 2008

Endo Pharmaceuticals Holdings Board Approves $750 Million Stock Buyback Program

CHADDS FORD, Pa. (AP) -- Endo Pharmaceuticals Holdings Inc. said Wednesday its board of directors approved a buyback program for $750 million in common stock.

Endo said it will buy the stock from time-to-time on the open market, in privately negotiated transactions, and accelerated stock repurchase transactions or otherwise.

The company had about 134.1 million shares outstanding as of Feb. 15, according to regulatory filings.

Shares of Endo rose 5 cents to $24.90 in after-hours trading after falling 15 cents to close at $24.85.

No comments: